Eventum Orthopaedics Ltd

Eventum Orthopaedics is a UK-based medical device company founded in 2020, headquartered in Yorkshire, England. The company specializes in orthopedic surgical technology focused on improving patient outcomes in total knee arthroplasty (TKA). Their flagship product, Quadsense, is an intraoperative measurement system that provides real-time data on patellofemoral joint loading during knee replacement surgery, enabling surgeons to optimize kneecap positioning and soft tissue tension—a critical factor in reducing postoperative patient dissatisfaction. Quadsense received FDA 510(k) clearance in September 2024 and is protected under UK Patent GB2596906 and European Patent EP4157156B1, with three additional patents pending including US process patents. The company is developing Datasense, a complementary data analysis platform integrating preoperative, intraoperative, and postoperative metrics to support surgical decision-making. Eventum has secured £1.4 million in funding from Mercia Ventures and angel investors, including support from prominent orthopedic surgeons. The team combines expertise in orthopedic surgery, product development, medical device sales, engineering, and data analytics. The company targets the global TKA market, which encompasses approximately 2 million procedures annually, projected to reach 3.5 million by 2030. Eventum's technology addresses a documented clinical need: approximately 20% of TKA patients report dissatisfaction postoperatively, with anterior knee pain affecting approximately 8% of patients. The company markets to orthopedic surgeons and surgical centers seeking to improve functional outcomes and reduce revision rates.